Assiri Asaad Mohamed Abdullah
Department of Pediatrics, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
Pediatr Rep. 2010 Jun 18;2(1):e4. doi: 10.4081/pr.2010.e4.
The aim of this study is to assess the prevalence of isolated short stature as a clinical presentation of celiac disease in Saudi Arab children and whether some of the routine laboratory tests performed to determine the cause of short stature could suggest the diagnosis of celiac disease. A total of 91 children with short stature were included in the study. Extensive endocrine and biochemical assessments, including total protein, serum albumin, calcium phosphate and alkaline phosphatase assays; renal function tests; coagulation profile; anti-endomysial antibodies and anti-tissue transglutaminase antibody, growth hormone, thyroid stimulating hormone, free-thyroxin (FT4) assays; stool tests for giardiasis; bone age; and endoscopic intestinal biopsies, were done for all children. Ten of the 91 children had positive intestinal biopsies in the form of total villous atrophy, an increase in crypt height, and an increase in intra-epithelial lymphocyte (IEL) numbers up to >40 IEL/100 EC (Type 3C) according to the Oberhuber classification, confirming the diagnosis of celiac disease. Five children had mild villous atrophy according to this classification (Type 3A), and they were considered to have potential celiac disease. Seventy-six children had normal intestinal biopsies. Therefore, the prevalence of celiac disease among Saudi children with short stature was 10.9%, and 4.3% of the children were diagnosed as having potential celiac disease. After confirming the diagnosis of celiac disease, all children were kept on a gluten-free diet and all of them showed improvement in their growth rate. We concluded that celiac disease is a very important cause of short stature in children without gastrointestinal complaints in Saudi Arabia. We highly recommend anti-tissue transglutaminase and anti-endomysial antibody screening tests, and a small bowel biopsy to confirm the diagnosis of celiac disease irrespective of the results of the antibody assays, in children with short stature in Saudi Arabia. Once the diagnosis is confirmed, children should be kept on a gluten-free diet so they can catch up their growth early before they develop permanent short stature.
本研究的目的是评估沙特阿拉伯儿童中作为乳糜泻临床表现的单纯性身材矮小的患病率,以及一些用于确定身材矮小原因的常规实验室检查是否能提示乳糜泻的诊断。共有91名身材矮小的儿童纳入本研究。对所有儿童进行了广泛的内分泌和生化评估,包括总蛋白、血清白蛋白、钙磷和碱性磷酸酶检测;肾功能检查;凝血指标;抗肌内膜抗体和抗组织转谷氨酰胺酶抗体、生长激素、促甲状腺激素、游离甲状腺素(FT4)检测;贾第虫病粪便检测;骨龄;以及内镜下肠道活检。根据奥伯胡伯分类,91名儿童中有10名肠道活检呈阳性,表现为全绒毛萎缩、隐窝高度增加以及上皮内淋巴细胞(IEL)数量增加至>40 IEL/100 EC(3C型),确诊为乳糜泻。根据该分类,有5名儿童有轻度绒毛萎缩(3A型),他们被认为患有潜在乳糜泻。76名儿童肠道活检正常。因此,沙特身材矮小儿童中乳糜泻的患病率为10.9%,4.3%的儿童被诊断为患有潜在乳糜泻。确诊乳糜泻后,所有儿童均采用无麸质饮食,他们的生长速度均有所改善。我们得出结论,在沙特阿拉伯,乳糜泻是无胃肠道症状儿童身材矮小的一个非常重要的原因。我们强烈建议,对于沙特身材矮小的儿童,无论抗体检测结果如何,均应进行抗组织转谷氨酰胺酶和抗肌内膜抗体筛查试验以及小肠活检以确诊乳糜泻。一旦确诊,儿童应采用无麸质饮食,以便在发展为永久性身材矮小之前尽早追赶生长。